SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-108140
Filing Date
2022-10-12
Accepted
2022-10-12 17:00:27
Documents
4
Period of Report
2022-11-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2227864-1_def14a.htm DEF 14A 534631
2 GRAPHIC lg_petros-4clr.jpg GRAPHIC 25735
3 GRAPHIC tm2227864d1-px_proxy1bw.jpg GRAPHIC 560736
4 GRAPHIC tm2227864d1-px_proxy2bw.jpg GRAPHIC 555889
  Complete submission text file 0001104659-22-108140.txt   2109287
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39752 | Film No.: 221307333
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences